Skip to main content

Day: January 4, 2022

SpringWorks Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

STAMFORD, Conn., Jan. 04, 2022 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 am ET. A video webcast will be available on the Events & Presentations page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for a limited time following the conference. About SpringWorks TherapeuticsSpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing...

Continue reading

Annexon Biosciences to Present at the 40th Annual J.P. Morgan Healthcare Conference

BRISBANE, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a new class of complement medicines for patients with classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders, today announced that Douglas Love, Esq., President & Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 3:45 p.m. ET. A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. About Annexon Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a new class of complement medicines...

Continue reading

Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference

WAYNE, Pa., Jan. 04, 2022 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 4:30 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor section of the Teleflex website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

Continue reading

PureGold Transitions to Operational Leadership Team and Provides Project Update

VANCOUVER, British Columbia, Jan. 04, 2022 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (TSX-V:PGM, LSE:PUR) (“PureGold” or the “Company”), announced today proactive executive management changes which better align operational requirements with professional expertise. Mr. Troy Fierro, Director and seasoned mining engineer, has replaced Darin Labrenz as President & CEO. Mr. Chris Haubrich, Vice President Business Development, has replaced Sean Tetzlaff as CFO. Ms. Ashley Kates, Corporate Controller, has been promoted to Vice President Finance & Corporate Secretary. All changes are effective as of January 1, 2022. Graeme Currie, Chairman, stated, “On behalf of the board of directors and all PureGold stakeholders, I thank both Darin and Sean for their dedication, commitment, and hard work dating back to the inception of the Company....

Continue reading

Red Pine Updates on its December 31 Warrant Exercising

TORONTO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX, OTCQB: RDEXF) (“Red Pine” or the “Company”) is pleased to report on the outcome of warrant holder’s exercising of the Company’s December 31, 2021, warrants. All amounts are in CAD dollars unless otherwise specified. Red Pine further announces that 8,302,059, or 82% of the outstanding warrants to purchase common shares of the Company that expired on December 31st, 2021, with a strike price of $0.50, have been exercised. The balance of the outstanding warrants expired at 5:00 p.m. Eastern time on December 31st, 2021. These exercises resulted in proceeds of CAD $4.04 million. As previously announced, Red Pine’s largest shareholder, Alamos Gold Inc., has exercised 100% of their warrants and currently owns approximately 19.43% of the Company’s outstanding...

Continue reading

Information on the total number of voting rights and shares in Tarkett’s share capital as of December 31th, 2021

PARIS, FRANCE, January 4th, 2022 – Information on the total number of voting rights and shares in Tarkett’s share capital as of December 31th, 2021 (Article L233-8-II of the French Commercial Code andArticle 223-16 of the General Regulation of the Autorité des marchés financiers)Date Total number of shares in the share capital Total number of voting rightsAs of December 31th, 2021   65,550,281   Number of theoretical voting rights: 65,799,763Number of exercisable voting rights: 65,552,208** After deduction of the treasury shares without voting rights. *** Group General CounselTarkett – Audrey Dauvet – audrey.dauvet@tarkett.com Media contacts Tarkett – communication@tarkett.com Brunswick – tarkett@brunswickgroup.com – Tel.: +33 (0) 1 53 96 83 83 About Tarkett With a history of 140 years, Tarkett is...

Continue reading

BioRestorative Therapies Awarded an STTR Phase I Grant to Explore the Therapeutic Effects of PEG-Peptide Hydrogel-Encapsulated Hypoxic Bone Marrow Stem Cells

MELVILLE, N.Y., Jan. 04, 2022 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on stem cell-based therapies, today announced that it has been awarded a Small Business Technology Transfer (STTR) Phase I grant for $256,000. The funds will be used specifically to evaluate the therapeutic effects on the Company’s hypoxic cultured bone marrow derived mesenchymal stem cells (BRTX-100) after encapsulation with a PEG-peptide hydrogel. The work is being done in collaboration with Dr. Lori Setton, Chair of the Department of Biomedical Engineering at Washington University in St. Louis. Dr. Setton developed the hydrogel from a PEG backbone conjugated with a proprietary formulation of peptides mimicking laminin and other matrix proteins selected for their...

Continue reading

Brunswick Corporation signs Virtual Power Purchase Agreement with Vesper Energy to offset electricity demand with renewable solar energy

METTAWA, Ill., Jan. 04, 2022 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) has entered into a virtual power purchase agreement (VPPA) with Vesper Energy (“Vesper”) to offset a majority of the projected electrical power needs of Brunswick’s global operations through clean solar energy. Under the multi-year agreement, Vesper, a leading developer, owner, and operator of utility-scale renewable energy assets will deliver an estimated 57MW of renewable energy annually to the North American grid. The solar energy will be generated from Vesper’s 500 MW Hornet Solar project in Texas, which is targeted to be fully operational by the end of 2023. Vesper has commercialized over 680 MW of solar projects in the U.S. and has an existing 3 GW solar and 2.5 GWh energy storage development pipeline. “We are proud to take the next step toward...

Continue reading

Bonum Bank Plc: POP Bank selects Crosskey as its core banking system partner

BONUM BANK PLCSTOCK EXCHANGE RELEASE4.1.2022, at 13.00 EET BONUM PANK PLC: POP Bank selects Crosskey as its core banking system partner POP Bank has today signed a cooperation agreement with Crosskey on the renewal of its core banking system. POP Bank anticipates that it will introduce the new core banking system during 2025. The cooperation agreement has no immediate effect on the daily banking services offered by the Bank. POP Bank’s goal for renewing its core banking system is to develop the bank’s customer experience and overall competitiveness. Crosskey is Finland’s leading provider of financial sector IT solutions. Its systems serve more than 3.5 million end-customers “The POP Bank Group’s vision is to be a bank that combines personal and digital services, has the highest level of customer satisfaction and a quick decision-making...

Continue reading

Radware Schedules Conference Call for Its Fourth Quarter and Full Year 2021 Earnings

TEL AVIV, Israel, Jan. 04, 2022 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a leading provider of cyber security and application delivery solutions, will announce its fourth quarter and full year 2021 financial results on Wednesday, February 9, 2022. Conference Call DetailsRadware management will host a call on Wednesday, February 9, 2022, at 8:30 a.m. EST to discuss its fourth quarter and full year 2021 results and the outlook for the first quarter of 2022. Participants are advised to join the call approximately 15 minutes before the start time. US: 1-888-510-2008 (toll free) International: 1-646-960-0306Conference ID: 1864701 The call will be webcast live on the Company’s website at http://www.radware.com/ir/investor-events/. A replay of the call will be available for two days, starting two hours after the end of the call,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.